Moderna expects $18.4 billion in 2021 sales from Covid vaccine, chief medical officer to depart

Earnings

A Moderna (COVID-19) vaccine is seen at the LA Mission homeless shelter on Skid Row, in Los Angeles, California, U.S., February 10, 2021.

Lucy Nicholson | Reuters

Moderna said Thursday it expects to make $18.4 billion in sales from its Covid-19 vaccine this year.

In releasing its fourth-quarter earnings, Moderna also said its chief medical officer, Tal Zaks, will leave the company in late September.

Shares of Moderna were up 3.9% in premarket trading.

The news comes a day after the company said it was expecting to produce at least 700 million Covid vaccine doses this year. It also said it expects to produce up to 1.4 billion Covid-19 vaccine doses in 2022.

Pfizer, which also has a vaccine authorized for use in the United States, said earlier this month that it expected to sell about $15 billion in doses this year.

This is a developing story. Please check back for updates.

Products You May Like

Articles You May Like

6 million people applied for unemployment a year ago. They’re still near pre-pandemic highs
Inside Larry Ellison’s $1 Billion Real Estate Portfolio
Biden tax plan may lead to more Roth retirement accounts
Real estate entrepreneur aims to be first to reach space and the bottom of the ocean within a year
Tying the knot sometimes means paying more in taxes. Here’s when the ‘marriage penalty’ kicks in

Leave a Reply

Your email address will not be published. Required fields are marked *